Cytotoxic effect of betulinic acid and betulinic acid acetate isolated from Melaleuca cajuput on human myeloid leukemia (HL-60) cell line

African Journal of Biotechnology

Volumn 9, Issue 38, 2010, Pages 6387-6396

  Faujan, N H ^a   Alitheen, N B ^a   Yeap, S K ^a   Ali, A M ^b   Muhajir, A H ^a   Ahmad, F B H ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

Author keywords

Betulinic acid; Cell cycle PI; Cytotoxicity; DNA laddering; HL 60; MTT assay

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 O (2',2' DIMETHYLSUCCINYL)BETULINIC ACID; 3 O SUCCINYLBETULINIC ACID; BETULIC ACID; BETULIC ACID ACETATE; BETULINIC ACID BENZOATE; DOXORUBICIN; MELALEUCA CAJUPUT EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA CONTENT; DNA FRAGMENTATION; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; FLOW CYTOMETRY; HISTOGRAM; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LEUKEMIA CELL; MELALEUCA; MELALEUCA CAJUPUT; MYELOID LEUKEMIA;

MELALEUCA; MURINAE;

EID: 77957989388     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ahmad FBH, Issak A, Basri M, Hana N, Yasin Y, Ali AM (2005). Synthesis of 3S-acetoxy-lup -20(29)-ene-28-decanoate using lipase as the catalyse. Chem. Environ. Res. 14(3-4): 207-213.
2. Ahmad FBH, Hassan VU, Zakaria R and Ali J (1997). Triterpenes from the seed of M. Cajuput. Oriental J. Chem. 13(3): 231-233.
3. Arita D, Kambe M, Ishioka C, Kanamaru R (1997). Induction of p53-independent apoptosis associated with G2M arrest following DNA damage in human colon cancer cell lines. Jpn. J. Cancer Res. 88(1): 39-43.
4. Baltina LA, Flekhter OB, Nigmatullina LR, Boreko EI, Pavlova NI, Nikolaeva SN, Savinova OV, Tolstikov GA (2003). Lupane triterpenes and derivatives with antiviral activity. Bioorg. Med. Chem. Lett. 13(20): 3549-3552.
5. Berger JM, Wang JC (1996). Recent developments in DNA topoisomerase II structure and mechanism. Curr. Opin. Struct. Biol. 6(1): 84-90.
6. Bicknell GR, Cohen GM (1995). Cleavage of DNA to large kilobase pair fragments occurs in some forms of necrosis as well as apoptosis. Biochem Biophys. Res. Commun. 207(1): 40-47.
7. Brown G, Choudhry MA, Durham J, Drayson MT, Michell RH (1999). Monocytically differentiating HL60 cells proliferate rapidly before they mature. Exp. Cell Res. 253(2): 511-518.
8. Chowdhury AR, Mandal S, Goswami A, Ghosh M, Mandal L, Chakraborty D, Ganguly A, Tripathi G, Mukhopadhyay S, Bandyopadhyay S, Majumderi H (2003). Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy. Mol. Med. Jan-Feb. 9(1-2): 26-36.
9. Cohen JJ (1993). Apoptosis: the physiologic pathway of cell death. Hosp. Pract. (Off Ed). 28(12): 35-43.
10. De Clercq E (1995). Antiviral therapy for human immunodeficiency virus infections. Clin. Microbial. Rev. 8: 200-239.
11. Dou QP, An B, Will PL (1995). Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc. Natl. Acad. Sci. USA, 92(20): 9019-9023.
12. Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E (1995). Leukemia. 9(6): 1013-1024.
13. Eisenbrand G, Pool-Zobel B, Baker V, Balls M, Blaauboer BJ, Boobis A, Carere A, Kevekordes S, Lhuguenot JC, Pieters R, Kleiner (2002). Methods of in vitro toxicology. Food Chem. Toxicol. Feb-Mar. 40(2-3): 193-236.
14. Fulda S, Jeremias I, Steiner HH, Pietsh T, Debatin KM (1999). Betulinic acid: a new cytotoxic agent against malignant brains tumor cells. Int. J. Cancer. 82(3): 435-441.
15. Fulda S, Susin SA, Kroemer G, Debatin KM (1998). Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 58: 4453-4460.
16. Fulda S, Scaffidi C, Santos A, Susin SA, Krammer PH, Kroemer G, Peter ME, Debatin KM (1998). Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol Chem. 273(51): 33942-33948.
17. Gauthier C, Legault J, Rondeau S, Pichette A (2009). Synthesis of betulinic acid acyl glucuronide for application in anticancer prodrug monotherapy. Tetrahedron Lett. 50: 988-991.
18. Geran RI, Greenberg NH, Macdonald MM, Schumacher AM, Abbott BJ (1972). Protocols for screening chemical agents and natural products against animal tumors and other biological systems (3rd Edition). Cancer Chemot. Rep. 3: 1-104.
19. Graham-Evans B, Tchounwou PB, Cohly HH (2003). Cytotoxicity and proliferation studies with arsenic in established human cell lines: keratinocytes, melanocytes, dendritic cells, dermal fibroblasts, microvascular endothelial cells, monocytes and T-cells. Int. J. Mol. Sci. 4: 13-21.
20. Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P (2004). Comparison of alamar blue and MTT assays for high through-put screening. Toxicol in vitro. 18(5): 703-710.
21. Hashimoto F, Kashiwada Y, Cosentino LM, Chen CH, Garrett PE, Lee KH (1997). Anti-AIDS-agents-XXVII.-Synthesis-and-anti-HIV-activityof-betulinic-acid-and-dihydrobetulinic-acid-derivatives. Bioorg. Med. Chem. 5(12): 2133-2143.
22. Hata K, Hori K, Ogasawara H, Takahashi S (2003). Anti-leukemia activities of Lup-28-al-20(29)-en-3-one, a lupane triterpene. Toxicol Lett. 143(1): 1-7.
23. Huang L, Ho P, Lee KH, Chen CH (2006). Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives. Bioorg Med Chem. 14(7): 2279-2289.
24. Ji ZN, Ye WC, Liu GQ, Huang Y (2002). Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells. Planta Med. 68(7): 596-600
25. Kaufmann SH (1989). Induction of endonucleolytic DNA cleavage in human acute mylogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drug: a cautionary note. Cancer Res. 49(21): 5870-5878.
26. Kessler JH, Mullauer FB, De Roo GM, Medema JP (2007). Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types. Cancer Lett. 251(1): 132-145.
27. Lennon SV, Martina SJ, Cotter TJ (1991). Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif. 24(2): 203-214.
28. Liu WK, Ho JC, Cheung FW, Liu BP, Ye WC, Che CT (2004). Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line. Eur. J. Pharmacol. 498(1-3): 71-78.
29. Maurya SK, Devi S, Pandey VB (1989). Content of betulin and betulinic acid, antitumor agents of Zizyphus species. Fitoterapia, 60(5): 468-469.
30. Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65(1-2): 55-63.
31. Mukherjee R, Jaggi M, Rajendran P (2004). Betulinic acid and its derivatives as anti-angiogenic agents. Bioorg. Med. Chem. Lett. 14(9): 2181-2184.
32. Mukherjee PK, Saha K, Das J, Pal M, Saha BP (1997). Studies on antiimflammatory activity of rhizomes of Nelumbo nucifera. Planta Med. 63(4): 367-369.
33. Mutai C, Abatis D, Vagias C, Moreauc D, Roussakis C, Roussis V (2004). Cytotoxic lupane-type triterpenoids from Acacia mellifera. Phytochem. 65(8): 1159-1164.
34. Parlova NI, Savinova OV, Nikolaeva SN, Boreko EI, Flekhter OB (2003). Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses. Fitoterapia, 74: 489-492
35. Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CW, Fong, HH, Kinghorn AD, Brown DM (1995). Discovery of betulinic acid as a selective inhibitor of melanoma that functions by induction of apoptosis. Nat. Med. 1(10): 1046-1050.
36. Poon KH, Zhang J, Wang C, Tse AK, Wan CK, Fong WF (2004). Betulinic acid enhances 1alpha, 25-dihydroxyvitamin D3-induced differentiation in human HL-60 promyelocytic leukemia cells. Anticancer Drugs, 15(6): 619-24.
37. Qian K, Nakagawa-Goto K, Yu D, Morris-Natschke LM, Nitz TJ, Kilgore N, Allaway GP, Lee KH (2007). Anti-AIDS agents 73: Structureactivity relationship study and asymmetric synthesis of 3-Omonomethylsuccinyl-betulinic acid derivatives. Bioorg. Med. Chem. Lett. 17(23): 6553-6557.
38. Raghuvar Gopal DV, Narkar AA, Badrinath Y, Mishra KP, Joshi DS (2005). Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl. Toxicol Lett. 155(3): 343-351.
39. Roy MK, Thalang VN, Trakoontivakorn G, Nakahara K (2004). Mechanism of mahanine-induced apoptosis in human leukemia cells (HL-60). Biochem. Pharmacol. 67(1): 41-51.
40. Samejima K, Tone S, Earnshaw WC (2001). CAAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis, J. Biol. Chem. 276: 45427-45432.
41. Schmid I, Uittenbogaart CH, Giorgi JV (1997). Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry, 15(1): 12-20.
42. Schmidt ML, Kuzmanoff KL, Ling-Indeck L, Pezzuto JM (1997). Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur. J. Cancer. 33(12): 2007-2010.
43. Surh YJ, Park KK, Chun KS, Lee LJ, Lee E, Lee SS (1999). Anti-tumorpromoting activities of selected pungent phenolic substances present in ginger. J. Environ. Pathol. Toxicol. Oncol. 18(2): 131-139.
44. Walker PR, Kokileva L, LeBlanc J, Sikorska M (1993). Detection of the initial stages of DNA fragmentation in apoptosis. Biotechniques, 15(6): 1032-1040.
45. Zhang J, Xu M (2002). Apoptotic DNA fragmentation and tissue homeostasis. Trends Cell Biol. 12(2): 84-89.
46. Zhang X, Hu M, Lan Y, Yu M, Chen BD (2000). Cleavage of bcl-2 protein by activated caspase-3 is associated with inactivation of lyn (p53/56) kinase activity in human M-07e leukemic cells during apoptosis. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 8(3): 166-175.
47. Ziegler HL, Franzyk H, Sairafianpour M, Tabatabai M, Tehrani MD, Bagherzadeh K, Hagerstrand H, Stærka D, Jaroszewskia JW (2004). Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth: structure-activity relationships for betulinic acid analogues. Bioorg. Med. Chem. 12(1): 119-127.
48. Zuco V, Rhigetti SC, Cleris E, Marchesi L, Passerini CG, Formelli F (2002). Selective cytotoxicity of betulinic acid on tumor cell lines but not normal cells. Cancer Lett. 175(1): 17-25.